Journal of Epidemiology and Public Health
Vol 6, No 2 (2021)

Meta-Analysis the Association between Chronic Obstructive Pulmonary Disease Comorbidity and COVID-19 Mortality

Daniyar, Pamogsa Ratri Adha (Unknown)
Kristiyanto, Agus (Unknown)
Rahardjo, Setyo Sri (Unknown)



Article Info

Publish Date
12 Apr 2021

Abstract

disease that hit the world community at the end of 2019. The risk of death from COVID-19 is highly dependent on age and previous health conditions. COVID-19 severe and critical symptoms are more commonly found in older patients and patients who have chronic comor­bidities such as cardio­vascular disease, hyper­tension, diabetes, including COPD. This study aims to deter­mine the relationship between COPD and mortality of COVID-19 patients in hospitals.Subjects and Method: This a meta-analysis study using the PRISMA flowchart guidelines. The article search process was carried out between 2020-2021 using databases from PubMed, Google Scholar, Science Direct, BMJ Garuda, SINTA, and National Library. Based on the database, there were 9 articles that met the inclusion criteria. The analysis was carried out using RevMan 5.3 software.Results: A total of 9 articles reviewed in the meta-analysis showed that comorbid COPD had a statistically significant association with hos­pital mortality of COVID-19 patients (aOR = 1.51; 95% CI= 1.21 to 1.9; p < 0.001).Conclusion: COPD comorbidities have an increased risk of dying of COVID-19 patients in hospital.Keywords: CPOD, COVID-19, death, meta-analysisCorrespondence: Pamogsa Ratri Adha Daniyar. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java. Email: pamogsadaniyar@gmail.com. Mobile: +62 852-9060-1552.Journal of Epidemiology and Public Health (2021), 06(02): 222-231https://doi.org/10.26911/jepublichealth.2021.06.02.09

Copyrights © 2021






Journal Info

Abbrev

jepublichealth

Publisher

Subject

Public Health

Description

Background: Increased blood pressure for a long time can increase the risk of kidney failure, co­ronary heart disease, brain damage, and other di­seases. In 2019, it is estimated that hyper­tens­ion is experienced by 1.13 billion people in the world with most (two thirds) living in low and ...